Abstracts cont. Clinical Microbiology and Infection Clinical Microbiology and Infection Volume 10, Pages 87-178 (January 2004) DOI: 10.1111/j.1469-0691.2004.0902b.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
Figure 1 Decrease of clinical symptoms over 10 days from start of MXF therapy Clinical Microbiology and Infection 2004 10, 87-178DOI: (10.1111/j.1469-0691.2004.0902b.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
Clinical Microbiology and Infection 2004 10, 87-178DOI: (10. 1111/j Clinical Microbiology and Infection 2004 10, 87-178DOI: (10.1111/j.1469-0691.2004.0902b.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
Figure 1 Monthly %MRSA for ICU and Non-ICU beds. Aberdeen Royal Infirmary, January 1996–March 2003 Clinical Microbiology and Infection 2004 10, 87-178DOI: (10.1111/j.1469-0691.2004.0902b.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
Clinical Microbiology and Infection 2004 10, 87-178DOI: (10. 1111/j Clinical Microbiology and Infection 2004 10, 87-178DOI: (10.1111/j.1469-0691.2004.0902b.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
16S-23S rDNA multiplex-PCR Nocardia Clinical Microbiology and Infection 2004 10, 87-178DOI: (10.1111/j.1469-0691.2004.0902b.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions